Radiologic-pathologic Correlation at Breast MR Imaging: What is the Appropriate Management for High-risk Lesions?

Magnetic Resonance Imaging Clinics of North America

Volumn 21, Issue 3, 2013, Pages 583-599

  Heller, Samantha L ^a   Hernandez, Ozvaldo ^b   Moy, Linda ^b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast; High risk lesions; Magnetic resonance imaging; Radiologic pathologic correlation

Indexed keywords

ATYPICAL DUCTAL HYPERPLASIA; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST DISEASE; BREAST LESION; BREAST PAPILLOMA; BREAST SURGERY; CELL DIFFERENTIATION; CELL PROLIFERATION; CORRELATION ANALYSIS; FLAT EPITHELIAL ATYPIA; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

EID: 84881378102     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2013.03.001     Document Type: Review

References (65)

1. Nunes L.W., Schnall M.D., Orel S.G., et al. Breast MR imaging: interpretation model. Radiology 1997, 202:833-841.
2. Nunes L.W., Schnall M.D., Siegelman E.S., et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol 1997, 169:409-415.
3. Schnall M.D., Blume J., Bluemke D.A., et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006, 238:42-53.
4. Gutierrez R.L., DeMartini W.B., Eby P.R., et al. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol 2009, 193:994-1000.
5. Mahoney M.C., Gatsonis C., Hanna L., et al. Positive predictive value of BI-RADS MR imaging. Radiology 2012, 264:51-58.
6. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999, 211:101-110.
7. Kuhl C.K., Schrading S., Bieling H.B., et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007, 370:485-492.
8. Jansen S.A. Ductal carcinoma in situ: detection, diagnosis, and characterization with magnetic resonance imaging. Semin Ultrasound CT MR 2011, 32:306-318.
9. Rosen E.L., Smith-Foley S.A., DeMartini W.B., et al. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J 2007, 13:545-550.
10. Jansen S.A., Newstead G.M., Abe H., et al. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007, 245:684-691.
11. Vag T., Baltzer P.A., Dietzel M., et al. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis. Acta Radiol 2010, 51:955-961.
12. Heller S.L., Moy L. Imaging features and management of high-risk lesions on contrast-enhanced dynamic breast MRI. AJR Am J Roentgenol 2012, 198:249-255.
13. Niell B., Specht M., Gerade B., et al. Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?. AJR Am J Roentgenol 2012, 199:929-935.
14. Rausch D.R., Hendrick R.E. How to optimize clinical breast MR imaging practices and techniques on Your 1.5-T system. Radiographics 2006, 26:1469-1484.
15. Leung J.W. Utility of second-look ultrasound in the evaluation of MRI-detected breast lesions. Semin Roentgenol 2011, 46:260-274.
16. Linda A., Zuiani C., Furlan A., et al. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?. AJR Am J Roentgenol 2012, 198:272-280.
17. Londero V., Zuiani C., Linda A., et al. High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol 2012, 199:W240-W250.
18. Tavassoli F.A., Norris H.J. Acomparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 1990, 65:518-529.
19. Masood S., Rosa M. Borderline breast lesions: diagnostic challenges and clinical implications. Adv Anat Pathol 2011, 18:190-198.
20. Strigel R.M., Eby P.R., Demartini W.B., et al. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI. AJR Am J Roentgenol 2010, 195:792-798.
21. Perretta T., Pistolese C.A., Bolacchi F., et al. MR imaging-guided 10-gauge vacuum-assisted breast biopsy: histological characterisation. Radiol Med 2008, 113:830-840.
22. Carbognin G., Girardi V., Brandalise A., et al. MR-guided vacuum-assisted breast biopsy in the management of incidental enhancing lesions detected by breast MR imaging. Radiol Med 2011, 116:876-885.
23. Lehman C.D., Deperi E.R., Peacock S., et al. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol 2005, 184:1782-1787.
24. Liberman L., Holland A.E., Marjan D., et al. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 2007, 188:684-690.
25. Crystal P., Sadaf A., Bukhanov K., et al. High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted?. Eur Radiol 2011, 21:582-589.
26. Parsian S., Rahbar H., Allison K.H., et al. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology 2012, 265:696-706.
27. Chen X., Lehman C.D., Dee K.E. MRI-guided breast biopsy: clinical experience with 14-gauge stainless steel core biopsy needle. AJR Am J Roentgenol 2004, 182:1075-1080.
28. Ghate S.V., Rosen E.L., Soo M.S., et al. MRI-guided vacuum-assisted breast biopsy with a handheld portable biopsy system. AJR Am J Roentgenol 2006, 186:1733-1736.
29. Han B.K., Schnall M.D., Orel S.G., et al. Outcome of MRI-guided breast biopsy. AJR Am J Roentgenol 2008, 191:1798-1804.
30. Liberman L., Morris E.A., Dershaw D.D., et al. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol 2003, 181:1283-1293.
31. Liberman L., Bracero N., Morris E., et al. MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR Am J Roentgenol 2005, 185:183-193.
32. Mahoney M.C. Initial clinical experience with a new MRI vacuum-assisted breast biopsy device. JMagn Reson Imaging 2008, 28:900-905.
33. Orel S.G., Rosen M., Mies C., et al. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience. Radiology 2006, 238:54-61.
34. Perlet C., Heywang-Kobrunner S.H., Heinig A., et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer 2006, 106:982-990.
35. Tozaki M., Yamashiro N., Sakamoto M., et al. Magnetic resonance-guided vacuum-assisted breast biopsy: results in 100 Japanese women. Jpn J Radiol 2010, 28:527-533.
36. Page D.L., Dupont W.D., Rogers L.W. Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol 1988, 19:201-207.
37. Tavassoli F.A. Lobular neoplasia: evolution of its significance and morphologic spectrum. Int J Surg Pathol 2010, 18:174S-177S.
38. Foote F.W., Stewart F.W. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 1941, 17:491-496.3.
39. Haagensen C.D., Lane N., Lattes R., et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978, 42:737-769.
40. Brem R.F., Lechner M.C., Jackman R.J., et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol 2008, 190:637-641.
41. Cangiarella J., Guth A., Axelrod D., et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med 2008, 132:979-983.
42. Brogi E., Murray M.P., Corben A.D. Lobular carcinoma, not only a classic. Breast J 2010, 16(Suppl 1):S10-S14.
43. Chivukula M., Haynik D.M., Brufsky A., et al. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 2008, 32:1721-1726.
44. Malhaire C., El Khoury C., Thibault F., et al. Vacuum-assisted biopsies under MR guidance: results of 72 procedures. Eur Radiol 2010, 20:1554-1562.
45. Noroozian M., Gombos E.C., Chikarmane S., et al. Factors that impact the duration of MRI-guided core needle biopsy. AJR Am J Roentgenol 2010, 194:W150-W157.
46. Friedlander L.C., Roth S.O., Gavenonis S.C. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 2011, 261:421-427.
47. Sung J.S., Malak S.F., Bajaj P., et al. Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 2011, 261:414-420.
48. Rabban J.T., Sgroi D.C. Sclerosing lesions of the breast. Semin Diagn Pathol 2004, 21:42-47.
49. Georgian-Smith D., Lawton T.J. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective. Radiol Clin North Am 2010, 48:999-1012.
50. Douglas-Jones A.G., Denson J.L., Cox A.C., et al. Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy. JClin Pathol 2007, 60:295-298.
51. Piubello Q., Parisi A., Eccher A., et al. Flat epithelial atypia on core needle biopsy: which is the right management?. Am J Surg Pathol 2009, 33:1078-1084.
52. Lerwill M.F. Flat epithelial atypia of the breast. Arch Pathol Lab Med 2008, 132:615-621.
53. Schnitt S.J. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res 2003, 5:263-268.
54. Verschuur-Maes A.H., van Deurzen C.H., Monninkhof E.M., et al. Columnar cell lesions on breast needle biopsies: is surgical excision necessary? A systematic review. Ann Surg 2012, 255:259-265.
55. Ueng S.H., Mezzetti T., Tavassoli F.A. Papillary neoplasms of the breast: a review. Arch Pathol Lab Med 2009, 133:893-907.
56. Mulligan A.M., O'Malley F.P. Papillary lesions of the breast: a review. Adv Anat Pathol 2007, 14:108-119.
57. Bhattarai N., Kanemaki Y., Kurihara Y., et al. Intraductal papilloma: features on MR ductography using a microscopic coil. AJR Am J Roentgenol 2006, 186:44-47.
58. Tominaga J., Hama H., Kimura N., et al. Magnetic resonance imaging of intraductal papillomas of the breast. JComput Assist Tomogr 2011, 35:153-157.
59. Daniel B.L., Gardner R.W., Birdwell R.L., et al. Magnetic resonance imaging of intraductal papilloma of the breast. Magn Reson Imaging 2003, 21:887-892.
60. Zhu Y., Zhang S., Liu P., et al. Solitary intraductal papillomas of the breast: MRI features and differentiation from small invasive ductal carcinomas. AJR Am J Roentgenol 2012, 199:936-942.
61. Rauch G.M., Dogan B.E., Smith T.B., et al. Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol 2012, 198:292-299.
62. Brennan S.B., Corben A., Liberman L., et al. Papilloma diagnosed at MRI-guided vacuum-assisted breast biopsy: is surgical excision still warranted?. AJR Am J Roentgenol 2012, 199:W512-W519.
63. Lee K.A., Zuley M.L., Chivukula M., et al. Risk of malignancy when microscopic radial scars and microscopic papillomas are found at percutaneous biopsy. AJR Am J Roentgenol 2012, 198:W141-W145.
64. Oxner C.R., Vora L., Yim J., et al. Magnetic resonance imaging-guided breast biopsy in lesions not visualized by mammogram or ultrasound. Am Surg 2012, 78:1087-1090.
65. Dogan B.E., Le-Petross C.H., Stafford J.R., et al. MRI-guided vacuum-assisted breast biopsy performed at 3 T with a 9-gauge needle: preliminary experience. AJR Am J Roentgenol 2012, 199:W651-W653.